Fasinumab (Anti-NGF / bNGF)
Fasinumab (Anti-NGF / bNGF) is a human IgG1k monoclonal antibody targeting nerve growth factor (NGF). It can be used in acute sciatica and knee osteoarthritis (OA) studies. MW :144.9 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A3008 |
Sku # | A3008-1mg*5 |
Pricing | 1mg*5, $1690.00 |